Fluidigm Corporation (NASDAQ:FLDM) headquartered in South San Francisco, will host a conference call for the investment community to discuss the 3Q20 financial results on 5th November 2020 at 5:00 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website www.fluidigm.com
Earnings Expectation
Fluidigm Corporation is expected to report third quarter earnings results, after market close, on Thursday 5th November 2020. Analysts polled by Thomson Reuters anticipate third quarter loss of $ 0.2 per share from revenue of $ 32.46 million. Looking ahead, the full year loss are expected at $ 0.7 per share on the revenues of $ 131.93 million.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 126.62 million ~ $ 130.14 million
Click Here For More Historical Outlooks Of Fluidigm Corporation
Fluidigm Corporation creates, manufactures, and markets technologies and tools for life sciences research in the United States and Europe. It offers analytical systems comprising Helios, a CyTOF system, Hyperion imaging system, and Hyperion tissue imager; and assays and reagents, including Maxpar reagents and Maxpar human immune monitoring panel kit and workflow. The company also provides preparatory instruments, such as access array and Juno systems; and analytical instruments comprising Biomark HD system and EP1 system.
